ALX Oncology to present results from phase 1b/2 trial of evorpacept in combo with zanidatamab at SABCS 2024: South San Francisco, California Tuesday, November 5, 2024, 12:00 Hrs [ ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback